Your browser doesn't support javascript.
loading
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.
Zwaginga, Jaap J; van der Holt, Bronno; Te Boekhorst, Peter A; Biemond, Bart J; Levin, Mark-David; van der Griend, René; Brand, Anneke; Zweegman, Sonja; Pruijt, Hans F M; Novotny, Vera M J; Vreugdenhil, Art; de Groot, Marco R; de Weerdt, Okke; van Pampus, Elisabeth C M; van Maanen-Lamme, Tanja M; Wittebol, Shulamiet; Schipperus, Martin R; Silbermann, Matthijs H; Huijgens, Peter C; Luten, Marleen; Hollestein, Rene; Brakenhoff, Jan A C; Schrama, Jolanda G; Valster, Fransje A A; Velders, Gerjo A; Koene, Harry R.
Afiliação
  • Zwaginga JJ; Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center and the Jon J van Rood Center for Clinical Transfusion Research, Sanquin-Leiden University Medical Center, The Netherlands j.j.zwaginga@lumc.nl.
  • van der Holt B; HOVON Data Center, Erasmus MC Cancer Institute - Clinical Trial Center, Rotterdam.
  • Te Boekhorst PA; Dept. of Hematology, Erasmus MC, Rotterdam.
  • Biemond BJ; Dept. of Hematology, Academic Medical Center Amsterdam, The Netherlands.
  • Levin MD; Dept. of Internal Medicine, Albert Schweitzer Hospital, Dordrecht.
  • van der Griend R; Department of Internal Medicine, Diakonessenhuis, Utrecht.
  • Brand A; Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center and the Jon J van Rood Center for Clinical Transfusion Research, Sanquin-Leiden University Medical Center, The Netherlands.
  • Zweegman S; Dept. of Hematology, VU University Medical Center, Amsterdam.
  • Pruijt HF; Dept. of Internal Medicine, Jeroen Bosch Hospital, Den Bosch.
  • Novotny VM; Dept. of Hematology, Radboud University Medical Centre, Nijmegen.
  • Vreugdenhil A; Dept of Internal Medicine, Máxima Medical Center, Veldhoven.
  • de Groot MR; Dept. of Internal Medicine, Medisch Spectrum Twente, Enschede.
  • de Weerdt O; Dept. of Internal Medicine, St. Antonius Hospital, Nieuwegein.
  • van Pampus EC; Dept. of Laboratory Medicine, Radboud University Medical Center, Nijmegen.
  • van Maanen-Lamme TM; Dept. of Internal Medicine, Westfriesgasthuis, Hoorn.
  • Wittebol S; Dept. of Internal Medicine, Meander Hospital, Amersfoort.
  • Schipperus MR; Dept. of Internal Medicine, HagaZiekenhuis, Den Haag.
  • Silbermann MH; Dept. of Internal Medicine, Tergooiziekenhuizen, Blaricum.
  • Huijgens PC; Dept. of Hematology, VU University Medical Center, Amsterdam.
  • Luten M; HOVON Data Center, Erasmus MC Cancer Institute - Clinical Trial Center, Rotterdam.
  • Hollestein R; HOVON Data Center, Erasmus MC Cancer Institute - Clinical Trial Center, Rotterdam.
  • Brakenhoff JA; Waterland hospital, Purmerend.
  • Schrama JG; Dept. of Internal Medicine, Spaarne hospital, Hoofddorp.
  • Valster FA; Dept. of Internal Medicine, Lievensberg Hospital, Bergen op Zoom, The Netherlands.
  • Velders GA; Dept. of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands.
  • Koene HR; Dept. of Internal Medicine, St. Antonius Hospital, Nieuwegein.
Haematologica ; 100(3): e90-2, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25425692
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática / Anticorpos Monoclonais Murinos / Fatores Imunológicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática / Anticorpos Monoclonais Murinos / Fatores Imunológicos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article